68001-492-36 |
68001-492 |
HUMAN PRESCRIPTION DRUG |
Doxorubicin Hydrochloride |
Doxorubicin Hydrochloride |
INJECTABLE, LIPOSOMAL |
INTRAVENOUS |
20210531 |
N/A |
ANDA |
ANDA203263 |
BluePoint Laboratories |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 PACKAGE (68001-492-36) / 10 mL in 1 VIAL, SINGLE-DOSE |
68001-493-26 |
68001-493 |
HUMAN PRESCRIPTION DRUG |
Doxorubicin Hydrochloride |
Doxorubicin Hydrochloride |
INJECTABLE, LIPOSOMAL |
INTRAVENOUS |
20210531 |
N/A |
ANDA |
ANDA203263 |
BluePoint Laboratories |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 PACKAGE (68001-493-26) / 25 mL in 1 VIAL, SINGLE-DOSE |
72603-200-01 |
72603-200 |
HUMAN PRESCRIPTION DRUG |
Doxorubicin Hydrochloride |
Doxorubicin Hydrochloride |
INJECTABLE, LIPOSOMAL |
INTRAVENOUS |
20190529 |
N/A |
ANDA |
ANDA203263 |
NorthStar RxLLC |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 PACKAGE (72603-200-01) / 25 mL in 1 VIAL, SINGLE-DOSE |
72603-103-01 |
72603-103 |
HUMAN PRESCRIPTION DRUG |
Doxorubicin Hydrochloride |
Doxorubicin Hydrochloride |
INJECTABLE, LIPOSOMAL |
INTRAVENOUS |
20190529 |
N/A |
ANDA |
ANDA203263 |
NorthStar RxLLC |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 PACKAGE (72603-103-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
47335-049-40 |
47335-049 |
HUMAN PRESCRIPTION DRUG |
Doxorubicin Hydrochloride |
Doxorubicin Hydrochloride |
INJECTABLE, LIPOSOMAL |
INTRAVENOUS |
20130205 |
N/A |
ANDA |
ANDA203263 |
Sun Pharmaceutical Industries, Inc. |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 PACKAGE (47335-049-40) / 10 mL in 1 VIAL, SINGLE-DOSE |
47335-050-40 |
47335-050 |
HUMAN PRESCRIPTION DRUG |
Doxorubicin Hydrochloride |
Doxorubicin Hydrochloride |
INJECTABLE, LIPOSOMAL |
INTRAVENOUS |
20130205 |
N/A |
ANDA |
ANDA203263 |
Sun Pharmaceutical Industries, Inc. |
DOXORUBICIN HYDROCHLORIDE |
2 mg/mL |
1 VIAL, SINGLE-DOSE in 1 PACKAGE (47335-050-40) / 25 mL in 1 VIAL, SINGLE-DOSE |